TD Cowen lowered the firm’s price target on Universal Health (UHS) to $230 from $245 and keeps a Buy rating on the shares. The firm updated its model following Q1 results. They recognize investor caution but believes the reaction is overdone.
Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on UHS:
- Universal Health price target lowered to $211 from $238 at Guggenheim
- Universal Health price target lowered to $190 from $216 at RBC Capital
- Universal Health price target lowered to $204 from $241 at Baird
- Universal Health downgraded to Market Perform from Outperform at Raymond James
- Universal Health Services Earnings Call Highlights Growth